Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jianpi Lishi Jiedu Granules for Postoperative Recurrence of Colorectal Advanced Adenomas
NCT07505056Phase 3Not yet recruiting
- Sponsor
- Nanjing First Hospital
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Jianpi Lishi Jiedu Granules in Colorectal Adenoma (CRA), sponsored by Nanjing First Hospital. Planned start May 2026; status: not yet recruiting.
02
Drugs
Jianpi Lishi Jiedu Granules
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT07505056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07505056.